Texas Oncology, Fort Worth — Fort Worth, Texas

Texas Oncology, Fort Worth is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology, Fort Worth has participated in 3 clinical trials.

Therapeutic areas: Relapsed or Refractory Multiple Myeloma, Metastatic Renal Cell Carcinoma, Non-small Cell Lung Cancer.

Sponsors: Amgen, NewLink Genetics Corporation, OSI Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology, Fort Worth?

Texas Oncology, Fort Worth has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology, Fort Worth conducted?

Texas Oncology, Fort Worth has 3 clinical trials on record. Their work covers Relapsed or Refractory Multiple Myeloma, Metastatic Renal Cell Carcinoma, Non-small Cell Lung Cancer.

Is Texas Oncology, Fort Worth accredited by Crixeo Health?

Texas Oncology, Fort Worth has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology, Fort Worth?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.